Health care providers say that regulators could do more to enforce commonsense limits on prior authorization and step therapy, according to a new series of reports from the Aimed Alliance.
Devastating. Awful. Miserable. That’s how patients and advocates described step therapy during a recent Derma Care Access Network policy panel on Capitol Hill.